Thor Medical Stock

NANOV

NO0010597883

Biotechnology & Medical Research

Market Closed - Oslo Bors 10:45:00 2026-10-16 EDT			5-day change	1st Jan Change
4.440 ^NOK	+3.02%		-0.34%	-15.43%

10-06	Thor Medical ASA Opens AlphaOne Production Facility At Herøya Industrial Park	CI
09-20	Thor Medical ASA(OB:TRMED) added to S&P Global BMI Index	CI

Last Transcript: Thor Medical

Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026

08-28

More transcripts

News in other languages: Thor Medical

08-20	Avis d'analystes du jour : ça bouge sur Michelin, Sartorius, Pandora et Merck KGaA
22-06-02	Actualización de las fuertes variaciones del día: EcoOnline despierta su sector, Klöckner ajuste después de dividendo
22-06-02	Point sur les fortes variations du jour : Saint-Gobain réveille son secteur, Esker trop prudent
21-02-19	Avis d'analystes du jour : L'Oréal, Air France KLM, Nestlé, Orange, Campari, Moncler, BioMérieux, Stratec...
21-02-19	Des PMI et des sorcières pour terminer la semaine

More news

Managers and Directors: Thor Medical

Manager	Title	Age	Since
Jasper Kurth CEO	Chief Executive Officer	41	2024-07-31
Brede Høyland Ellingsæter DFI	Director of Finance/CFO	37	2023-06-30
Sindre Hassfjell CTO	Chief Tech/Sci/R&D Officer	-	2023-05-31

Director	Title	Age	Since
Mimi Kristine Berdal BRD	Director/Board Member	67	2023-06-27
John Andersen CHM	Chairman	59	-
Jens Gisle Schnelle BRD	Director/Board Member	-	2025-04-23

More insiders

Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-10-16	NOK 4.440	+3.02%	2,019,987
26-10-15	NOK 4.310	-2.49%	2,050,584
26-10-14	NOK 4.420	+1.38%	997,841
26-10-13	NOK 4.360	-1.58%	1,469,560
26-10-12	NOK 4.430	-0.56%	1,075,235

Real-time Oslo Bors

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.440NOK

Average target price

4.200NOK

Spread / Average Target

-5.41%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - Thor Medical

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Thor Medical

Company calendar

Market Cap	1.88B 199M 177M 164M 149M 281M 18.86B 286M 1.97B 771M 9.84B 746M 730M 31.37B	P/E 2026 *	-24.7x	P/E 2027 *	-44.4x
Enterprise Value	2.07B 220M 195M 181M 165M 311M 20.84B 316M 2.17B 852M 10.87B 824M 806M 34.66B	EV / Sales 2026 *	104x	EV / Sales 2027 *	14.3x
Free-Float	75.21%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	NANOV	Real-time
CBOE	NANOo	Real-time
London S.E.	0R6Y	End-of-day quote
Nasdaq Stockholm	NANOVO	Delayed
Tradegate	8NN	Real-time
Deutsche Boerse AG	8NN	Delayed
London S.E.	0R6Y	Delayed
CBOE	0R6Y	Real-time
Börse Stuttgart	8NN	Delayed
Boerse Muenchen	8NN	Real-time
Berne S.E.	8NN	End-of-day quote

10-06	Thor Medical ASA Opens AlphaOne Production Facility At Herøya Industrial Park	CI
09-20	Thor Medical ASA(OB:TRMED) added to S&P Global BMI Index	CI
08-28	Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026
08-25	Thor Medical's COO, CFO Transitions to Dedicated COO Role	MT
08-24	Thor Medical Asa CFO Brede Ellingsæter to Transition into Full-Time COO Role	CI
08-18	Thor Medical Asa Alphaone Facility Officially Opened by Norwegian Prime Minister Jonas Gahr Støre	CI
08-05	Thor Medical Completes Maiden Thorium-228 Isotope Delivery from AlphaOne Plant	MT
08-04	Thor Medical Asa Completes First Customer Delivery from Alphaone Production Facility	CI
07-30	Thor Medical ASA Starts Commercial Production At AlphaOne Facility	CI
06-16	Thor Medical ASA Announces Retirement of Alf Bjørseth from EVP Business Development, Effective June 30, 2026	CI
05-29	Thor Medical ASA Enters Collaboration and Supply Agreement With Minerva Imaging	CI
05-29	Thor Medical Lands Deal to Supply Cancer Treatment Isotope	MT

10-07	Thor Medical : Norwegian Prime Minister Jonas Gahr Støre to Officially Open Thor Medical's AlphaOne Facility on October 19	PU
09-22	Thor Medical ASA: Cancellation of Subsequent Offering	PU
09-11	Thor Medical ASA: Completed Redelivery of Shares	PU
09-10	Thor Medical ASA: Primary Insider Notification in Relation to Redelivery of Shares	PU
09-10	Thor Medical ASA: Disclosure of Large Shareholding	PU

1 day	+3.02%
1 week	-0.34%
Current month	-0.67%
1 month	-6.03%
3 months	+3.62%
6 months	-11.38%
Current year	-15.43%

Thor Medical Stock

Stocks

NANOV

NO0010597883

Biotechnology & Medical Research

Valuation: Thor Medical

Chart: Thor Medical

Latest news: Thor Medical

Last Transcript: Thor Medical

Press Releases: Thor Medical

News in other languages: Thor Medical

Quotes and Performance

Price Extremes

Managers and Directors: Thor Medical

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

1 week	4.28	4.52
1 month	4.28	4.9
Current year	3.88	7.12
1 year	3.31	7.12
3 years	0.85	7.12
5 years	0.85	7.12
10 years	0.85	7.12

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/26/25	Scatec Innovation AS	Others	Company	31,577,399	10.0434%
6/18/25	Scatec Innovation AS	Buy	Company	3,000,000	0.9542%
5/2/25	Jens Gisle Schnelle	Exercice	Director	164,641	0.0524%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THOR MEDICAL	+3.02%	-0.34%	+24.02%	+228.89%	199M
WUXI APPTEC CO., LTD.	-6.60%	-8.56%	+49.38%	+63.51%	65B
LONZA GROUP AG	+0.03%	+5.56%	+9.10%	+69.05%	51.2B
ARGENX SE	-4.09%	-0.11%	+2.22%	+53.15%	51.19B
IQVIA HOLDINGS INC.	-1.53%	+2.70%	+30.48%	+34.12%	43.93B
BEONE MEDICINES AG	-1.34%	+4.12%	+16.64%	+115.13%	41.96B
REVOLUTION MEDICINES, INC.	-5.97%	-6.22%	+228.95%	+454.22%	38.14B
CELLTRION, INC.	+6.53%	+8.02%	+16.40%	+53.41%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	-3.70%	25.2B
GENMAB A/S	-1.07%	+2.33%	+19.43%	+9.98%	22.5B
Average	-1.19%	-0.35%	+43.37%	+107.78%	37.26B
Weighted average by Cap.	-2.19%	-0.50%	+44.24%	+96.60%

	2026 *	2027 *
Net sales	20M 2.12M 1.88M 1.75M 1.59M 3M 201M 3.04M 20.98M 8.22M 105M 7.95M 7.78M 334M	145M 15.36M 13.65M 12.65M 11.51M 21.72M 1.46B 22.07M 152M 59.63M 761M 57.63M 56.41M 2.42B
Net income	-70M -7.41M -6.59M -6.11M -5.56M -10.49M -704M -10.65M -73.42M -28.79M -367M -27.82M -27.23M -1.17B	-44M -4.66M -4.14M -3.84M -3.49M -6.59M -442M -6.7M -46.15M -18.09M -231M -17.49M -17.12M -736M
Net Debt	197M 20.86M 18.55M 17.19M 15.64M 29.51M 1.98B 29.99M 207M 81.01M 1.03B 78.3M 76.64M 3.29B	201M 21.29M 18.92M 17.54M 15.96M 30.11M 2.02B 30.59M 211M 82.66M 1.05B 79.89M 78.19M 3.36B